Why Attend?

2021 Agenda
Location & CLE

As the premier conference for the food and drug law community, the FDLI Annual Conference addresses complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. The conference provides in-depth discussions and analyses on a wide variety of timely topics by bringing together experts from the federal government, industry, the private bar, non-profit, patient and consumer advocates, consulting organizations, and academia.

Conference Highlights:

  • HearFDA’s strategic priorities directly from the FDA Commissioner, Chief Counsel, Center Directors, and other key leaders within the Agency
  • Gain in-depth knowledge of each FDA Center by attending consecutive Center Director sessions scheduled to maximize attendee opportunities
  • Join high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding
  • Select from over 30 breakout sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues
  • Learn from more than 100 well-known officials and experts
  • Hear about the Top Cases in Food and Drug Law
  • Network and build relationships with seasoned legal, regulatory, compliance, policy, and government professionals

Call For Proposals

FDLI invites you to submit a proposal for a session for the 2022 Annual Conference. Topics should address timely and important issues relating to legal, regulatory, compliance, policy, and marketing as it impacts any and all areas of the FDA-regulated community. Your submissions are integral to ensuring that the most pertinent topics are covered at the conference.


  • Topics should be at an advanced level
  • Topics can relate specifically to drugs, biologics, medical devices, veterinary products, cannabis products, tobacco and nicotine products, or food and dietary supplements or be relevant to all
  • Topics that include a variety of perspectives and viewpoints, including government, industry, private attorneys, academics, and public interest are preferred.
  • FDLI is committed to supporting, promoting, and celebrating diversity and inclusion in the food and drug law programs. To that end, proposals addressing systematic or historical impacts on health care disparity and racial equity in relation to all areas of the FDA-regulated community are strongly encouraged.
  • We prefer submissions to include a reasonably detailed and thoughtful title for and description of the proposed session.

Proposal Reminders

  • Multiple submissions from the same person or organization are welcome, but each proposal requires its own form.
  • All submissions are treated as recommendations, and proposals may be modified or combined by FDLI to best suit the needs of the conference.
  • All submissions are blinded before being reviewed by the Annual Conference Planning Committee.
  • All submissions must be received through the submission portal.
  • Speaking opportunities are generally reserved for FDLI members.

Proposal Submission Timeline

  • November 5: Call for Proposals closes.
  • Late January: Those who submitted proposals will be notified of their submission’s status at the end of January 2022.

Register by April 15, 2022 and SAVE!


Manufacturer & Firms

  • +$500 for non-members
  • +$200 after 4/15/2022
  • +$100 after 4/29/2022


  • +$200 for non-members
  • +$200 after 4/15/2022
  • +$100 after 4/29/2022


  • +$200 for non-members
  • +$200 after 4/15/2022
  • +$100 after 4/29/2022


  • +$200 for non-members
  • +$200 after 4/15/2022
  • +$100 after 4/29/2022


Sponsorship opportunities are available. Please let us know if you would like more information.

Planning Committee


Meredith Q. Olearchik
Campbell Soup Company


Vernessa T. Pollard
McDermott Will & Emery



To Be Announced